Market Cap 163.43M
Revenue (ttm) 2.04M
Net Income (ttm) -40.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,001.47%
Debt to Equity Ratio 11.40
Volume 3,145,124
Avg Vol 7,466,140
Day's Range N/A - N/A
Shares Out 222.02M
Stochastic %K 52%
Beta 2.11
Analysts Strong Sell
Price Target $5.07

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
gtzmoney
gtzmoney Apr. 17 at 5:57 PM
$HUMA let's get ti $5.00 bucks so I can sell
0 · Reply
malphius
malphius Apr. 17 at 3:49 PM
$HUMA Lets get it to .75 by the end of day
0 · Reply
jdkd4
jdkd4 Apr. 17 at 3:05 PM
$HUMA @jacksparo Nice profit profit off of yesterday‘s dip! With Jack, I just keep making money! Not a ton here but still 4K to take through the weekend. Thx Jack!!! I’m not done with the stock either. If it dips I’ll buy back.
1 · Reply
malphius
malphius Apr. 17 at 1:58 PM
$HUMA We are so close. Get in now before it's too late
0 · Reply
audiobookprisonstories
audiobookprisonstories Apr. 17 at 1:56 PM
$HUMA SHORTS!! BEWARE! 📊 HUMA Short Squeeze + Phase 3 Setup Short interest: ~42M shares (increasing) Days to cover: ~3 (down from ~9) 👉 More shorts = more fuel 👉 Lower days = faster, more violent moves if volume hits 🚀 If Phase 3 = Standard of Care (strong patency + lower infection) 📅 Day 1: 👉 $0.70 → $2$4 Immediate repricing Shorts start covering 🔥 Week 1: 👉 $3$5$7 Forced covering Momentum + retail pile in 📈 Month 1: 👉 $5$7$10+ Shorts mostly gone Institutions step in Market starts pricing TAM ⚠️ Key Insight Squeeze = fast (1–5 days) Re-rating = slower (weeks) 🎯 Bottom Line 👉 If data is strong, this becomes: Biotech breakout + short squeeze combo Immediate: $2$4 Week: $4$7 Month: $6$10+ possible 👉 ONLY if: Data is clearly strong Price holds gains
0 · Reply
jdkd4
jdkd4 Apr. 17 at 1:44 PM
$HUMA come on shorts! HUMA me!!!
0 · Reply
rubraquercus
rubraquercus Apr. 17 at 1:42 PM
$HUMA run for your lives, the sky is falling, bla bla bla, lol
0 · Reply
Runmaster83
Runmaster83 Apr. 17 at 1:39 PM
$HUMA F U Short Scum!
0 · Reply
malphius
malphius Apr. 17 at 12:32 PM
$HUMA 1/ June Catalyst V012 Phase 3 data drops in Early June. The clinical work is finished (116 enrolled). Waiting on the 12-month clock. 2/ Regulatory Shield Chair: Kathleen Sebelius (Former HHS Sec). She ran the FDA & Medicare. Her presence in an M&A Data Room completely neutralizes regulatory and reimbursement risk. 3/ Inside Connection Board: Dr. Diane Seimetz, former Fresenius CSO. Fresenius owns an 8.4% stake. She is a direct backchannel to the Apex Predator. 4/ The Closer Rick McElheny hired as SVP of Business Development. Background: Sold Vidara for $660M. You don't hire an M&A heavy-hitter weeks before Phase 3 data to sell tubes. You hire him to open the Data Room. 5/ Smart Money Floor Institutions hold ~45%. Marshall Wace (+5,300%) & Millennium (+129%) are aggressively accumulating. The $20M offering established a hard $0.80 floor. 6/ The Verdict Retail algorithms shake weak hands. Institutions front-run the June binary and CABG pipeline. Know what you hold. $HUMA
1 · Reply
Aceled
Aceled Apr. 17 at 11:56 AM
$HUMA since you bots like posting outdated news - here are some latest ones
1 · Reply
Latest News on HUMA
Humacyte To Participate in Upcoming Investor Conferences

Mar 2, 2026, 8:00 AM EST - 6 weeks ago

Humacyte To Participate in Upcoming Investor Conferences


Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 1 year ago

Trestle Bio Announces Research Collaboration with Humacyte


gtzmoney
gtzmoney Apr. 17 at 5:57 PM
$HUMA let's get ti $5.00 bucks so I can sell
0 · Reply
malphius
malphius Apr. 17 at 3:49 PM
$HUMA Lets get it to .75 by the end of day
0 · Reply
jdkd4
jdkd4 Apr. 17 at 3:05 PM
$HUMA @jacksparo Nice profit profit off of yesterday‘s dip! With Jack, I just keep making money! Not a ton here but still 4K to take through the weekend. Thx Jack!!! I’m not done with the stock either. If it dips I’ll buy back.
1 · Reply
malphius
malphius Apr. 17 at 1:58 PM
$HUMA We are so close. Get in now before it's too late
0 · Reply
audiobookprisonstories
audiobookprisonstories Apr. 17 at 1:56 PM
$HUMA SHORTS!! BEWARE! 📊 HUMA Short Squeeze + Phase 3 Setup Short interest: ~42M shares (increasing) Days to cover: ~3 (down from ~9) 👉 More shorts = more fuel 👉 Lower days = faster, more violent moves if volume hits 🚀 If Phase 3 = Standard of Care (strong patency + lower infection) 📅 Day 1: 👉 $0.70 → $2$4 Immediate repricing Shorts start covering 🔥 Week 1: 👉 $3$5$7 Forced covering Momentum + retail pile in 📈 Month 1: 👉 $5$7$10+ Shorts mostly gone Institutions step in Market starts pricing TAM ⚠️ Key Insight Squeeze = fast (1–5 days) Re-rating = slower (weeks) 🎯 Bottom Line 👉 If data is strong, this becomes: Biotech breakout + short squeeze combo Immediate: $2$4 Week: $4$7 Month: $6$10+ possible 👉 ONLY if: Data is clearly strong Price holds gains
0 · Reply
jdkd4
jdkd4 Apr. 17 at 1:44 PM
$HUMA come on shorts! HUMA me!!!
0 · Reply
rubraquercus
rubraquercus Apr. 17 at 1:42 PM
$HUMA run for your lives, the sky is falling, bla bla bla, lol
0 · Reply
Runmaster83
Runmaster83 Apr. 17 at 1:39 PM
$HUMA F U Short Scum!
0 · Reply
malphius
malphius Apr. 17 at 12:32 PM
$HUMA 1/ June Catalyst V012 Phase 3 data drops in Early June. The clinical work is finished (116 enrolled). Waiting on the 12-month clock. 2/ Regulatory Shield Chair: Kathleen Sebelius (Former HHS Sec). She ran the FDA & Medicare. Her presence in an M&A Data Room completely neutralizes regulatory and reimbursement risk. 3/ Inside Connection Board: Dr. Diane Seimetz, former Fresenius CSO. Fresenius owns an 8.4% stake. She is a direct backchannel to the Apex Predator. 4/ The Closer Rick McElheny hired as SVP of Business Development. Background: Sold Vidara for $660M. You don't hire an M&A heavy-hitter weeks before Phase 3 data to sell tubes. You hire him to open the Data Room. 5/ Smart Money Floor Institutions hold ~45%. Marshall Wace (+5,300%) & Millennium (+129%) are aggressively accumulating. The $20M offering established a hard $0.80 floor. 6/ The Verdict Retail algorithms shake weak hands. Institutions front-run the June binary and CABG pipeline. Know what you hold. $HUMA
1 · Reply
Aceled
Aceled Apr. 17 at 11:56 AM
$HUMA since you bots like posting outdated news - here are some latest ones
1 · Reply
Aceled
Aceled Apr. 17 at 11:52 AM
$HUMA this guy will tell the same tales when stock drops 0.2.... 5 years same story. 0 brain to understand that they need more cash for research than they can ever produce.
0 · Reply
Goldwave9
Goldwave9 Apr. 17 at 10:59 AM
$HUMA Folks. If this goes up it only proves that quality, management, and profitability are meaningless
1 · Reply
malphius
malphius Apr. 17 at 10:37 AM
$HUMA Shorts are completely out of ammo. This is a $10 stock once v012 drops.
1 · Reply
Aceled
Aceled Apr. 17 at 8:07 AM
$HUMA low volume, no new funds are investing, insiders are not buying and terrible cash burn. Non-stop dilutions. 25 years is enough to start making at least some revenue. Stop luring new investors just to get out - last days pumps are so manipulated by bots.
1 · Reply
Aceled
Aceled Apr. 17 at 8:03 AM
$HUMA bots stop spreading false outdated information... This company is trash with 0 revenue.
1 · Reply
malphius
malphius Apr. 16 at 11:15 PM
$HUMA Multiple events on the short-term horizon.
0 · Reply
crowbaby333
crowbaby333 Apr. 16 at 10:20 PM
0 · Reply
malphius
malphius Apr. 16 at 9:00 PM
$HUMA If we can run it back up to $1, call options should print. Plenty of good news on the horizon. Slam dunk.
0 · Reply
EasilyTricked
EasilyTricked Apr. 16 at 8:57 PM
$HUMA So common - 95% of small companies have great products but incompetent management that drive it into the ground and out of business or into a firesafe that destroys the investors. To me, that's a bigger crime than robbing a 7-11.
1 · Reply
ThedaB
ThedaB Apr. 16 at 8:47 PM
0 · Reply
gtzmoney
gtzmoney Apr. 16 at 7:58 PM
$HUMA I've been crying over a year
0 · Reply
Runmaster83
Runmaster83 Apr. 16 at 5:39 PM
$HUMA Notice they all wait until a red day to cry wolf….😂
1 · Reply